Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
05 May 2015Website:
http://www.opgen.comNext earnings report:
04 July 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:39:03 GMTDividend
Analysts recommendations
Institutional Ownership
OPGN Latest News
OpGen (NASDAQ: OPGN ) just reported results for the fourth quarter of 2023. OpGen reported earnings per share of -$17.67.
ROCKVILLE, Md., May 24, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company not filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), which serves as an additional basis for delisting the Company's securities from Nasdaq, and that the Nasdaq Hearings Panel will consider this matter in connection with the continued listing of the Company's securities on Nasdaq. Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all periodic reports with the Securities and Exchange Commission (the “SEC”).
OpGen, Inc. (Nasdaq: OPGN) announced today that its board of directors has approved a 1-for-10 reverse stock split of its common stock, which will be effective at 12:01 a.m. EST on May 20, 2024. The Company's common stock will begin trading on The Nasdaq Capital Market under the symbol "OPGN" on a post-split basis. The new CUSIP number for the Company's common stock after the Reverse Stock Split will be 68373L505.
OpGen (NASDAQ: OPGN ) stock is on the rise Friday after the precision medicine company withdrew a share offering. A filing with the Securities and Exchange Commission (SEC) has the company requesting the withdrawal of its Registration Statement on Form S-1.
OpGen Inc. (NASDAQ:OPGN ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Oliver Schacht – President and Chief Executive Officer Albert Weber – Chief Financial Officer Conference Call Participants Pooya Hemami – Edison Group Yi Chen – H.C. Wainwright Operator Welcome to the OpGen First Quarter 2023 Earnings Call and Business Update.
What type of business is OpGen?
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
What sector is OpGen in?
OpGen is in the Healthcare sector
What industry is OpGen in?
OpGen is in the Medical Devices industry
What country is OpGen from?
OpGen is headquartered in United States
When did OpGen go public?
OpGen initial public offering (IPO) was on 05 May 2015
What is OpGen website?
https://www.opgen.com
Is OpGen in the S&P 500?
No, OpGen is not included in the S&P 500 index
Is OpGen in the NASDAQ 100?
No, OpGen is not included in the NASDAQ 100 index
Is OpGen in the Dow Jones?
No, OpGen is not included in the Dow Jones index
When does OpGen report earnings?
The next expected earnings date for OpGen is 04 July 2024